Hikma Pharmaceutical reported 280M in EBIT for its first fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
AstraZeneca AZN:LN 1.4B 366M
Bayer BAYN:GR 1.64B 1.42B
Fresenius FRE:GR 1.04B 29M
Galapagos GLPG:NA -46750000 4.05M
Genmab GEN:DC 787M 255M
GlaxoSmithKline GSK:LN 1.96B 281M
GRIFOLS GRF:SM 245.2M 40.86M
H. Lundbeck A/S LUN:DC 596M 286M
Hikma Pharmaceutical HIK:LN 280M 2M
Lonza Group LONN:SW 599M 271M
Merck MRK:GR 1.16B 63M
Orion ORNBV:FH 71M 4M
Recordati REC:IM 126.04M 381K